Search for: "Novo Nordisk, Inc." Results 41 - 60 of 135
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
28 Jul 2013, 9:29 am by Spencer Aronfeld
  Some of the other diabetes drugs being investigated include Bydureon and Onglyza, sold by Bristol-Myers Squibb; AstraZeneca and Victoza from Novo Nordisk; Tradjenta from Eli Lilly and Boehringer Ingelheim; and Nesina from Takeda. [read post]
14 Aug 2012, 11:14 pm
Novo Nordisk, A/S, 108 F.3d 1361, 1365 (Fed. [read post]
19 Jun 2012, 12:59 am
" TechPharma Licensing v Novo Nordisk (BPAI 2012) was a reexamination appeal for claims to an injection needle. [read post]
25 May 2012, 8:45 am by Bexis
Novo Nordisk, A/S, No. 1009-13177 (Or. [read post]
22 May 2012, 6:22 am by Lawrence B. Ebert
Novo Nordisk, A/S, 108 F.3d 1361, 1366 (Fed. [read post]
17 Apr 2012, 5:55 pm by FDABlog HPM
Novo Nordisk A/S that “[a] generic manufacturer may employ the counterclaim provision to force correction of a use code that inaccurately describes the brand’s patent as covering a particular method of using a drug. [read post]
5 Apr 2012, 8:27 pm
District Court for the Southern District of New York against Novo Nordisk, Inc., a Danish pharmaceuticals company. [read post]